| Entry |
|
| Name |
HPV E5 to p21-cell cycle G1/S
|
| Definition |
E5 -| (CDKN1A,CDKN1B) |
| Expanded |
K21812 -| (1026,1027) |
| Class |
|
| Type |
Pathogen
|
| Pathway |
|
| Disease |
|
| Gene |
| 1026 | CDKN1A; cyclin dependent kinase inhibitor 1A |
| 1027 | CDKN1B; cyclin dependent kinase inhibitor 1B |
|
| Perturbant |
| K21812 (E5) | E5; HPV protein E5 |
|
| Reference |
|
| Authors |
de Freitas AC, Coimbra EC, Leitao Mda C |
| Title |
Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis. |
| Journal |
|
| Reference |
|
| Authors |
Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G |
| Title |
Papillomavirus E5: the smallest oncoprotein with many functions. |
| Journal |
|
| Reference |
|
| Authors |
DiMaio D, Petti LM |
| Title |
The E5 proteins. |
| Journal |
|
| Reference |
|
| Authors |
Tsao YP, Li LY, Tsai TC, Chen SL |
| Title |
Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes. |
| Journal |
|
| LinkDB |
|